Characteristics (n, except for age in years and PCI in score units) | Colorectal cancer |
---|---|
Age ā mean years (95% CI) | 55 (51ā59) |
Gender ā Male/Female | 21/31 |
IPC administered | 37 |
āāāSPIC | 7 |
āāāHIPEC | 30 |
āāāĀ Oxaliplatin | 12 |
āāāĀ Oxaliplatinā+āirinotecan | 18 |
PCI ā mean (95% CI) | 21 (18ā24) |
CC score | Ā |
āāā0 | 27 |
āāā1 | 5 |
āāā2 | 4 |
āāā3 | 16 |
Diagnosis | Ā |
āāāColon | 47 |
āāāRectum | 5 |
Preoperative chemo | 39 |
āāāOxaliplatin/5-FUāĀ±ābev | 30 |
āāāOxaliplatin/5-FUā+ācet | 1 |
āāāOxaliplatin/capecitabineāĀ±ābev | 4 |
āāāIrinotecan/5-FUā+ābev | 1 |
āāāCapecitabine | 1 |
āāā5-FU alone | 2 |
Adjuvant systemic chemo | 15 |
āāāOxaliplatin/5-FUāĀ±ābev | 8 |
āāāIrinotecan/5-FUāĀ±ābev | 2 |
āāāCapecitabine | 1 |
āāā5-FU alone | 1 |
āāāMissing data on drug | 3 |